Ventricular Assist Device Market: Global Industry Analysis and Forecast (2022-2029) – by Product, by Flow, by Design, by Application and by Region


Ventricular Assist Device Market was valued at US$ 2.55 Bn in 2021 and is expected to reach US$ 5.56 Bn by 2029, at a CAGR of 10.24% during the forecast period.

The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.
Ventricular Assist Device Market

To know about the Research Methodology :- Request Free Sample Report

Ventricular Assist Device Market Dynamics:

Ventricular assist devices are pumps, which are used to support cardiac circulation in patients who have weakened hearts. Growing occurrences of heart failure across the globe, innovative technological advancements in ventricular assist devices, increasing awareness among patients about monitoring of the heart, and lack of heart donors are some of the prominent factors behind the growth of the global ventricular assist device market.

Growing government funding for new product development coupled with ongoing research activities is expected to propel the growth of ventricular assist devices. New advancements in designs are also expected to boost the growth in demand. Innovative technologies contain the usage of centrifugal pumps, which precludes the blood from becoming static and escapes the risk of clotting.

The high cost of ventricular assist devices and the implantation procedures are limiting the growth in the global ventricular assist device market. The ventricular assist devices are available in the market on average costs around and the total procedure costs around. The cost of the device and procedures is excessive to the low and middle-income patient population, which is declining the demand for ventricular assist devices.

Ventricular Assist Device Market Segment Analysis:

The left ventricular assist devices are expected to lead the global ventricular assist device market. The leading position in the market can be attributed to the growing number of patients who are suffering from last-stage heart failure, development in technology like effectiveness, high survival rate, and reduced risk of the devices. A growing number of patients suffering from cardiac complications like cardiomyopathy, stroke, and class III & class IV heart failure are likely to need a heart transplant.

The destination therapy segment is projected to witness significant growth in the global ventricular assist device market. This therapy is one of the most preferred therapies, which is used in heart failure patients and creates a major and growing portion of the heart implants. The increasing usage of destination therapy for ventricular assist devices in patients suffering from end-stage heart failure is expected to propel the global ventricular assist device market growth.

Ventricular Assist Device Market Regional Insights:

Geographically, North America is estimated to hold a leading position in the global ventricular assist device market. The leading position in the market is attributed to the ongoing clinical trials for the testing of these devices and augmented government funding. Rising patient awareness about the availability of these ventricular assist devices and improved R&D activities for new product development is projected to boost the market growth. Furthermore, the Asia Pacific region is expected to grow at a xx % rate of CAGR during the forecast period. The region is projected to register productive growth during the forecast period (2022-2029) owing to the growing healthcare expenditure, and recent improvements in healthcare infrastructure in developing countries like China, Japan, and India.

The development and up-gradation of devices are expected to increase the competition among key players. Some of the many key players are focusing on product endorsements and developing innovative products to reinforce their product portfolio, which strengthens the market competition. For instance, in 2021 FDA approved HeartMate 3 left ventricular assist device, which is developed by Abbott, as a destination therapy for patients with innovative heart failure.

The objective of the report is to present a comprehensive assessment of the market and contain insights, facts, historical data, industry-validated market data, and projections with a suitable set of assumptions and methodology. The report also helps in understanding dynamics, structure by analyzing the market segments and, projects the global ventricular assist device market. The report also provides a clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global ventricular assist device market.

Ventricular Assist Device Market, Key Highlights:

• Global Ventricular Assist Device Market analysis and forecast, in terms of value.

• Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Ventricular Assist Device Market

• Global Ventricular Assist Device Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

• Global Ventricular Assist Device Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

• Global Ventricular Assist Device Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

• Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

• Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Ventricular Assist Device Market are also profiled.

Ventricular Assist Device Market Scope Report: Inquire before buying






Global Ventricular Assist Device Market




Report Coverage
Details




Base Year:
2021
Forecast Period:
2022-2029




Historical Data:
2017 to 2021
Market Size in 2021:
US$ 2.55 Bn.




Forecast Period 2022 to 2029 CAGR:
10.24%
Market Size in 2029:
US$ 5.56 Bn.




 Segments Covered:
by Product
• Left Ventricular Assist Device
• Right Ventricular Assist Device
• Bi-Ventricular Assist Device




by Flow
• Pulsatile Flow
• Continuous Flow




by Design
• Transcutaneous Ventricular Assist Devices
• Implantable Ventricular Assist Devices




by Application
• Bridge to Transplant
• Destination Therapy
• Bridge-to-recovery Therapy
• Bridge-to-candidacy Therapy
• Others






Ventricular Assist Device Market, by Region

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America

Ventricular Assist Device Market Key Players:

• CardiacAssist, Inc.
• Berlin Heart GmbH
• Jarvik Heart, Inc.
• ABIOMED, Inc.
• Medtronic plc.
• Abbott Laboratories
• ReliantHeart Inc.
• Teleflex Incorporated
• Carmat SA
• Sun Medical Technology Research Corp.
• Bivacor
• Calon Cardio-Technology Ltd.
• LivaNova PLC
• Terumo Medical Corporation.
• Evaheart Medical USA, Inc.
• Fresenius Medical Care AG & Co. KGaA
• Maquet GmbH
• HeartWare International, Inc.
• Thoratec
• Cardiac Assist

Frequently Asked Questions:

1. Which region has the largest share in Global Ventricular Assist Device Market?
Ans: North America region holds the highest share in 2021.

2. What is the growth rate of Global Ventricular Assist Device Market?
Ans: The Global Ventricular Assist Device Market is growing at a CAGR of 10.24% during forecasting period 2022-2029.

3. What is scope of the Global Ventricular Assist Device market report?
Ans: Global Ventricular Assist Device Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Ventricular Assist Device market?
Ans: The important key players in the Global Ventricular Assist Device Market are – CardiacAssist, Inc., Berlin Heart GmbH, Jarvik Heart, Inc., ABIOMED, Inc., Medtronic plc., Abbott Laboratories, ReliantHeart Inc., Teleflex Incorporated, Carmat SA, Sun Medical Technology Research Corp., Bivacor, Calon Cardio-Technology Ltd., LivaNova PLC, Terumo Medical Corporation., Evaheart Medical USA, Inc., Fresenius Medical Care AG & Co. KGaA, Maquet GmbH, HeartWare International, Inc., Thoratec, and Cardiac Assist

5. What is the study period of this market?
Ans: The Global Ventricular Assist Device Market is studied from 2021 to 2029. 





Global Ventricular Assist Device Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Ventricular Assist Device Market Size, by Market Value (US$ Bn) and Market Volume (Units)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7.Global Ventricular Assist Device Market Industry Trends
4.8.Global Ventricular Assist Device Market Competitive Landscape

5. Supply Side and Demand Side Indicators

6. Global Ventricular Assist Device Market Analysis and Forecast
6.1. Global Ventricular Assist Device Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Ventricular Assist Device Market Analysis and Forecast, by Product
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Ventricular Assist Device Market Value Share Analysis, by Product
7.4. Global Ventricular Assist Device Market Size (US$ Bn) Forecast, by Product
7.5. Global Ventricular Assist Device Market Analysis, by Product
7.6. Global Ventricular Assist Device Market Attractiveness Analysis, by Product

8. Global Ventricular Assist Device Market Analysis and Forecast, by Flow
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Ventricular Assist Device Market Value Share Analysis, by Flow
8.4. Global Ventricular Assist Device Market Size (US$ Bn) Forecast, by Flow
8.5. Global Ventricular Assist Device Market Analysis, by Flow
8.6. Global Ventricular Assist Device Market Attractiveness Analysis, by Flow

9. Global Ventricular Assist Device Market Analysis and Forecast, by Application
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Ventricular Assist Device Market Value Share Analysis, by Application
9.4. Global Ventricular Assist Device Market Size (US$ Bn) Forecast, by Application
9.5. Global Ventricular Assist Device Market Analysis, by Application
9.6. Global Ventricular Assist Device Market Attractiveness Analysis, by Application

10. Global Ventricular Assist Device Market Analysis and Forecast, by Design
10.1. Introduction and Definition
10.2. Key Findings
10.3. Global Ventricular Assist Device Market Value Share Analysis, by Design
10.4. Global Ventricular Assist Device Market Size (US$ Bn) Forecast, by Design
10.5. Global Ventricular Assist Device Market Analysis, by Design
10.6. Global Ventricular Assist Device Market Attractiveness Analysis, by Design

11. Global Ventricular Assist Device Market Analysis, by Region
11.1. Global Ventricular Assist Device Market Value Share Analysis, by Region
11.2. Global Ventricular Assist Device Market Size (US$ Bn) Forecast, by Region
11.3. Global Ventricular Assist Device Market Attractiveness Analysis, by Region

12. North America Ventricular Assist Device Market Analysis
12.1. Key Findings
12.2. North America Ventricular Assist Device Market Overview
12.3. North America Ventricular Assist Device Market Value Share Analysis, by Product
12.4. North America Ventricular Assist Device Market Forecast, by Product
12.4.1. Left Ventricular Assist Device
12.4.2. Right Ventricular Assist Device
12.4.3. Bi-Ventricular Assist Device
12.5. North America Ventricular Assist Device Market Value Share Analysis, by Flow
12.6. North America Ventricular Assist Device Market Forecast, by Flow
12.6.1. Pulsatile Flow
12.6.2. Continuous Flow
12.7. North America Ventricular Assist Device Market Value Share Analysis, by Application
12.8. North America Ventricular Assist Device Market Forecast, by Application
12.8.1. Bridge to Transplant
12.8.2. Destination Therapy
12.8.3. Bridge-to-recovery Therapy
12.8.4. Bridge-to-candidacy Therapy
12.8.5. Others
12.9. North America Ventricular Assist Device Market Value Share Analysis, by Design
12.10. North America Ventricular Assist Device Market Forecast, by Design
12.10.1. Transcutaneous Ventricular Assist Devices
12.10.2. Implantable Ventricular Assist Devices
12.11. North America Ventricular Assist Device Market Value Share Analysis, by Country
12.12. North America Ventricular Assist Device Market Forecast, by Country
12.12.1. U.S.
12.12.2. Canada
12.13. North America Ventricular Assist Device Market Analysis, by Country
12.14. U.S. Ventricular Assist Device Market Forecast, by Product
12.14.1. Left Ventricular Assist Device
12.14.2. Right Ventricular Assist Device
12.14.3. Bi-Ventricular Assist Device
12.15. U.S. Ventricular Assist Device Market Forecast, by Flow
12.15.1. Pulsatile Flow
12.15.2. Continuous Flow
12.16. U.S. Ventricular Assist Device Market Forecast, by Application
12.16.1. Bridge to Transplant
12.16.2. Destination Therapy
12.16.3. Bridge-to-recovery Therapy
12.16.4. Bridge-to-candidacy Therapy
12.16.5. Others
12.17. U.S. Ventricular Assist Device Market Forecast, by Design
12.17.1. Transcutaneous Ventricular Assist Devices
12.17.2. Implantable Ventricular Assist Devices
12.18. Canada Ventricular Assist Device Market Forecast, by Product
12.18.1. Left Ventricular Assist Device
12.18.2. Right Ventricular Assist Device
12.18.3. Bi-Ventricular Assist Device
12.19. Canada Ventricular Assist Device Market Forecast, by Flow
12.19.1. Pulsatile Flow
12.19.2. Continuous Flow
12.20. Canada Ventricular Assist Device Market Forecast, by Application
12.20.1. Bridge to Transplant
12.20.2. Destination Therapy
12.20.3. Bridge-to-recovery Therapy
12.20.4. Bridge-to-candidacy Therapy
12.20.5. Others
12.21. Canada Ventricular Assist Device Market Forecast, by Design
12.21.1. Transcutaneous Ventricular Assist Devices
12.21.2. Implantable Ventricular Assist Devices
12.22. North America Ventricular Assist Device Market Attractiveness Analysis
12.22.1. By Product
12.22.2. By Flow
12.22.3. By Application
12.22.4. By Design
12.23. PEST Analysis
12.24. Key Trends
12.25. Key Developments

13. Europe Ventricular Assist Device Market Analysis
13.1. Key Findings
13.2. Europe Ventricular Assist Device Market Overview
13.3. Europe Ventricular Assist Device Market Value Share Analysis, by Product
13.4. Europe Ventricular Assist Device Market Forecast, by Product
13.4.1. Left Ventricular Assist Device
13.4.2. Right Ventricular Assist Device
13.4.3. Bi-Ventricular Assist Device
13.5. Europe Ventricular Assist Device Market Value Share Analysis, by Flow
13.6. Europe Ventricular Assist Device Market Forecast, by Flow
13.6.1. Pulsatile Flow
13.6.2. Continuous Flow
13.7. Europe Ventricular Assist Device Market Value Share Analysis, by Application
13.8. Europe Ventricular Assist Device Market Forecast, by Application
13.8.1. Bridge to Transplant
13.8.2. Destination Therapy
13.8.3. Bridge-to-recovery Therapy
13.8.4. Bridge-to-candidacy Therapy
13.8.5. Others
13.9. Europe Ventricular Assist Device Market Value Share Analysis, by Design
13.10. Europe Ventricular Assist Device Market Forecast, by Design
13.10.1. Transcutaneous Ventricular Assist Devices
13.10.2. Implantable Ventricular Assist Devices
13.11. Europe Ventricular Assist Device Market Value Share Analysis, by Country
13.12. Europe Ventricular Assist Device Market Forecast, by Country
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Europe Ventricular Assist Device Market Analysis, by Country
13.14. Germany Ventricular Assist Device Market Forecast, by Product
13.14.1. Left Ventricular Assist Device
13.14.2. Right Ventricular Assist Device
13.14.3. Bi-Ventricular Assist Device
13.15. Germany Ventricular Assist Device Market Forecast, by Flow
13.15.1. Pulsatile Flow
13.15.2. Continuous Flow
13.16. Germany Ventricular Assist Device Market Forecast, by Application
13.16.1. Bridge to Transplant
13.16.2. Destination Therapy
13.16.3. Bridge-to-recovery Therapy
13.16.4. Bridge-to-candidacy Therapy
13.16.5. Others
13.17. Germany Ventricular Assist Device Market Forecast, by Design
13.17.1. Transcutaneous Ventricular Assist Devices
13.17.2. Implantable Ventricular Assist Devices
13.18. U.K. Ventricular Assist Device Market Forecast, by Product
13.18.1. Left Ventricular Assist Device
13.18.2. Right Ventricular Assist Device
13.18.3. Bi-Ventricular Assist Device
13.19. U.K. Ventricular Assist Device Market Forecast, by Flow
13.19.1. Pulsatile Flow
13.19.2. Continuous Flow
13.20. U.K. Ventricular Assist Device Market Forecast, by Application
13.20.1. Bridge to Transplant
13.20.2. Destination Therapy
13.20.3. Bridge-to-recovery Therapy
13.20.4. Bridge-to-candidacy Therapy
13.20.5. Others
13.21. U.K. Ventricular Assist Device Market Forecast, by Design
13.21.1. Transcutaneous Ventricular Assist Devices
13.21.2. Implantable Ventricular Assist Devices
13.22. France Ventricular Assist Device Market Forecast, by Product
13.22.1. Left Ventricular Assist Device
13.22.2. Right Ventricular Assist Device
13.22.3. Bi-Ventricular Assist Device
13.23. France Ventricular Assist Device Market Forecast, by Flow
13.23.1. Pulsatile Flow
13.23.2. Continuous Flow
13.24. France Ventricular Assist Device Market Forecast, by Application
13.24.1. Bridge to Transplant
13.24.2. Destination Therapy
13.24.3. Bridge-to-recovery Therapy
13.24.4. Bridge-to-candidacy Therapy
13.24.5. Others
13.25. France Ventricular Assist Device Market Forecast, by Design
13.25.1. Transcutaneous Ventricular Assist Devices
13.25.2. Implantable Ventricular Assist Devices
13.26. Italy Ventricular Assist Device Market Forecast, by Product
13.26.1. Left Ventricular Assist Device
13.26.2. Right Ventricular Assist Device
13.26.3. Bi-Ventricular Assist Device
13.27. Italy Ventricular Assist Device Market Forecast, by Flow
13.27.1. Pulsatile Flow
13.27.2. Continuous Flow
13.28. Italy Ventricular Assist Device Market Forecast, by Application
13.28.1. Bridge to Transplant
13.28.2. Destination Therapy
13.28.3. Bridge-to-recovery Therapy
13.28.4. Bridge-to-candidacy Therapy
13.28.5. Others
13.29. Italy Ventricular Assist Device Market Forecast, by Design
13.29.1. Transcutaneous Ventricular Assist Devices
13.29.2. Implantable Ventricular Assist Devices
13.30. Spain Ventricular Assist Device Market Forecast, by Product
13.30.1. Left Ventricular Assist Device
13.30.2. Right Ventricular Assist Device
13.30.3. Bi-Ventricular Assist Device
13.31. Spain Ventricular Assist Device Market Forecast, by Flow
13.31.1. Pulsatile Flow
13.31.2. Continuous Flow
13.32. Spain Ventricular Assist Device Market Forecast, by Application
13.32.1. Bridge to Transplant
13.32.2. Destination Therapy
13.32.3. Bridge-to-recovery Therapy
13.32.4. Bridge-to-candidacy Therapy
13.32.5. Others
13.33. Spain Ventricular Assist Device Market Forecast, by Design
13.33.1. Transcutaneous Ventricular Assist Devices
13.33.2. Implantable Ventricular Assist Devices
13.34. Rest of Europe Ventricular Assist Device Market Forecast, by Product
13.34.1. Left Ventricular Assist Device
13.34.2. Right Ventricular Assist Device
13.34.3. Bi-Ventricular Assist Device
13.35. Rest of Europe Ventricular Assist Device Market Forecast, by Flow
13.35.1. Pulsatile Flow
13.35.2. Continuous Flow
13.36. Rest of Europe Ventricular Assist Device Market Forecast, by Application
13.36.1. Bridge to Transplant
13.36.2. Destination Therapy
13.36.3. Bridge-to-recovery Therapy
13.36.4. Bridge-to-candidacy Therapy
13.36.5. Others
13.37. Rest Of Europe Ventricular Assist Device Market Forecast, by Design
13.37.1. Transcutaneous Ventricular Assist Devices
13.37.2. Implantable Ventricular Assist Devices
13.38. Europe Ventricular Assist Device Market Attractiveness Analysis
13.38.1. By Product
13.38.2. By Flow
13.38.3. By Application
13.38.4. By Design
13.39. PEST Analysis
13.40. Key Trends
13.41. Key Developments

14. Asia Pacific Ventricular Assist Device Market Analysis
14.1. Key Findings
14.2. Asia Pacific Ventricular Assist Device Market Overview
14.3. Asia Pacific Ventricular Assist Device Market Value Share Analysis, by Product
14.4. Asia Pacific Ventricular Assist Device Market Forecast, by Product
14.4.1. Left Ventricular Assist Device
14.4.2. Right Ventricular Assist Device
14.4.3. Bi-Ventricular Assist Device
14.5. Asia Pacific Ventricular Assist Device Market Value Share Analysis, by Flow
14.6. Asia Pacific Ventricular Assist Device Market Forecast, by Flow
14.6.1. Pulsatile Flow
14.6.2. Continuous Flow
14.7. Asia Pacific Ventricular Assist Device Market Value Share Analysis, by Application
14.8. Asia Pacific Ventricular Assist Device Market Forecast, by Application
14.8.1. Bridge to Transplant
14.8.2. Destination Therapy
14.8.3. Bridge-to-recovery Therapy
14.8.4. Bridge-to-candidacy Therapy
14.8.5. Others
14.9. Asia Pacific Ventricular Assist Device Market Value Share Analysis, by Design
14.10. Asia Pacific Ventricular Assist Device Market Forecast, by Design
14.10.1. Transcutaneous Ventricular Assist Devices
14.10.2. Implantable Ventricular Assist Devices
14.11. Asia Pacific Ventricular Assist Device Market Value Share Analysis, by Country
14.12. Asia Pacific Ventricular Assist Device Market Forecast, by Country
14.12.1. China
14.12.2. India
14.12.3. Japan
14.12.4. ASEAN
14.12.5. Rest of Asia Pacific
14.13. Asia Pacific Ventricular Assist Device Market Analysis, by Country
14.14. China Ventricular Assist Device Market Forecast, by Product
14.14.1. Left Ventricular Assist Device
14.14.2. Right Ventricular Assist Device
14.14.3. Bi-Ventricular Assist Device
14.15. China Ventricular Assist Device Market Forecast, by Flow
14.15.1. Pulsatile Flow
14.15.2. Continuous Flow
14.16. China Ventricular Assist Device Market Forecast, by Application
14.16.1. Bridge to Transplant
14.16.2. Destination Therapy
14.16.3. Bridge-to-recovery Therapy
14.16.4. Bridge-to-candidacy Therapy
14.16.5. Others
14.17. China Ventricular Assist Device Market Forecast, by Design
14.17.1. Transcutaneous Ventricular Assist Devices
14.17.2. Implantable Ventricular Assist Devices
14.18. India Ventricular Assist Device Market Forecast, by Product
14.18.1. Left Ventricular Assist Device
14.18.2. Right Ventricular Assist Device
14.18.3. Bi-Ventricular Assist Device
14.19. India Ventricular Assist Device Market Forecast, by Flow
14.19.1. Pulsatile Flow
14.19.2. Continuous Flow
14.20. India Ventricular Assist Device Market Forecast, by Application
14.20.1. Bridge to Transplant
14.20.2. Destination Therapy
14.20.3. Bridge-to-recovery Therapy
14.20.4. Bridge-to-candidacy Therapy
14.20.5.
14.20.6. Others
14.21. India Ventricular Assist Device Market Forecast, by Design
14.21.1. Transcutaneous Ventricular Assist Devices
14.21.2. Implantable Ventricular Assist Devices
14.22. Japan Ventricular Assist Device Market Forecast, by Product
14.22.1. Left Ventricular Assist Device
14.22.2. Right Ventricular Assist Device
14.22.3. Bi-Ventricular Assist Device
14.23. Japan Ventricular Assist Device Market Forecast, by Flow
14.23.1. Pulsatile Flow
14.23.2. Continuous Flow
14.24. Japan Ventricular Assist Device Market Forecast, by Application
14.24.1. Bridge to Transplant
14.24.2. Destination Therapy
14.24.3. Bridge-to-recovery Therapy
14.24.4. Bridge-to-candidacy Therapy
14.24.5. Others
14.25. Japan Ventricular Assist Device Market Forecast, by Design
14.25.1. Transcutaneous Ventricular Assist Devices
14.25.2. Implantable Ventricular Assist Devices
14.26. ASEAN Ventricular Assist Device Market Forecast, by Product
14.26.1. Left Ventricular Assist Device
14.26.2. Right Ventricular Assist Device
14.26.3. Bi-Ventricular Assist Device
14.27. ASEAN Ventricular Assist Device Market Forecast, by Flow
14.27.1. Pulsatile Flow
14.27.2. Continuous Flow
14.28. ASEAN Ventricular Assist Device Market Forecast, by Application
14.28.1. Bridge to Transplant
14.28.2. Destination Therapy
14.28.3. Bridge-to-recovery Therapy
14.28.4. Bridge-to-candidacy Therapy
14.28.5. Others
14.29. ASEAN Ventricular Assist Device Market Forecast, by Design
14.29.1. Transcutaneous Ventricular Assist Devices
14.29.2. Implantable Ventricular Assist Devices
14.30. Rest of Asia Pacific Ventricular Assist Device Market Forecast, by Product
14.30.1. Left Ventricular Assist Device
14.30.2. Right Ventricular Assist Device
14.30.3. Bi-Ventricular Assist Device
14.31. Rest of Asia Pacific Ventricular Assist Device Market Forecast, by Flow
14.31.1. Pulsatile Flow
14.31.2. Continuous Flow
14.32. Rest of Asia Pacific Ventricular Assist Device Market Forecast, by Application
14.32.1. Bridge to Transplant
14.32.2. Destination Therapy
14.32.3. Bridge-to-recovery Therapy
14.32.4. Bridge-to-candidacy Therapy
14.32.5. Others
14.33. Rest of Asia Pacific Ventricular Assist Device Market Forecast, by Design
14.33.1. Transcutaneous Ventricular Assist Devices
14.33.2. Implantable Ventricular Assist Devices
14.34. Asia Pacific Ventricular Assist Device Market Attractiveness Analysis
14.34.1. By Product
14.34.2. By Flow
14.34.3. By Application
14.34.4. By Design
14.35. PEST Analysis
14.36. Key Trends
14.37. Key Developments

15. Middle East & Africa Ventricular Assist Device Market Analysis
15.1. Key Findings
15.2. Middle East & Africa Ventricular Assist Device Market Overview
15.3. Middle East & Africa Ventricular Assist Device Market Value Share Analysis, by Product
15.4. Middle East & Africa Ventricular Assist Device Market Forecast, by Product
15.4.1. Left Ventricular Assist Device
15.4.2. Right Ventricular Assist Device
15.4.3. Bi-Ventricular Assist Device
15.5. Middle East & Africa Ventricular Assist Device Market Value Share Analysis, by Flow
15.6. Middle East & Africa Ventricular Assist Device Market Forecast, by Flow
15.6.1. Pulsatile Flow
15.6.2. Continuous Flow
15.7. Middle East & Africa Ventricular Assist Device Market Value Share Analysis, by Application
15.8. Middle East & Africa Ventricular Assist Device Market Forecast, by Application
15.8.1. Bridge to Transplant
15.8.2. Destination Therapy
15.8.3. Bridge-to-recovery Therapy
15.8.4. Bridge-to-candidacy Therapy
15.8.5. Others
15.9. Middle East & Africa Ventricular Assist Device Market Value Share Analysis, by Design
15.10. Middle East & Africa Ventricular Assist Device Market Forecast, by Design
15.10.1. Transcutaneous Ventricular Assist Devices
15.10.2. Implantable Ventricular Assist Devices
15.11. Middle East & Africa Ventricular Assist Device Market Value Share Analysis, by Country
15.12. Middle East & Africa Ventricular Assist Device Market Forecast, by Country
15.12.1. GCC
15.12.2. South Africa
15.12.3. Rest of Middle East & Africa
15.13. Middle East & Africa Ventricular Assist Device Market Analysis, by Country
15.14. GCC Ventricular Assist Device Market Forecast, by Product
15.14.1. Left Ventricular Assist Device
15.14.2. Right Ventricular Assist Device
15.14.3. Bi-Ventricular Assist Device
15.15. GCC Ventricular Assist Device Market Forecast, by Flow
15.15.1. Pulsatile Flow
15.15.2. Continuous Flow
15.16. GCC Ventricular Assist Device Market Forecast, by Application
15.16.1. Bridge to Transplant
15.16.2. Destination Therapy
15.16.3. Bridge-to-recovery Therapy
15.16.4. Bridge-to-candidacy Therapy
15.16.5. Others
15.17. GCC Ventricular Assist Device Market Forecast, by Design
15.17.1. Transcutaneous Ventricular Assist Devices
15.17.2. Implantable Ventricular Assist Devices
15.18. South Africa Ventricular Assist Device Market Forecast, by Product
15.18.1. Left Ventricular Assist Device
15.18.2. Right Ventricular Assist Device
15.18.3. Bi-Ventricular Assist Device
15.19. South Africa Ventricular Assist Device Market Forecast, by Flow
15.19.1. Pulsatile Flow
15.19.2. Continuous Flow
15.20. South Africa Ventricular Assist Device Market Forecast, by Application
15.20.1. Bridge to Transplant
15.20.2. Destination Therapy
15.20.3. Bridge-to-recovery Therapy
15.20.4. Bridge-to-candidacy Therapy
15.20.5. Others
15.21. South Africa Ventricular Assist Device Market Forecast, by Design
15.21.1. Transcutaneous Ventricular Assist Devices
15.21.2. Implantable Ventricular Assist Devices
15.22. Rest of Middle East & Africa Ventricular Assist Device Market Forecast, by Product
15.22.1. Left Ventricular Assist Device
15.22.2. Right Ventricular Assist Device
15.22.3. Bi-Ventricular Assist Device
15.23. Rest of Middle East & Africa Ventricular Assist Device Market Forecast, by Flow
15.23.1. Pulsatile Flow
15.23.2. Continuous Flow
15.24. Rest of Middle East & Africa Ventricular Assist Device Market Forecast, by Application
15.24.1. Bridge to Transplant
15.24.2. Destination Therapy
15.24.3. Bridge-to-recovery Therapy
15.24.4. Bridge-to-candidacy Therapy
15.24.5. Others
15.25. Rest of Middle East & Africa Ventricular Assist Device Market Forecast, by Design
15.25.1. Transcutaneous Ventricular Assist Devices
15.25.2. Implantable Ventricular Assist Devices
15.26. Middle East & Africa Ventricular Assist Device Market Attractiveness Analysis
15.26.1. By Product
15.26.2. By Flow
15.26.3. By Application
15.26.4. By Design
15.27. PEST Analysis
15.28. Key Trends
15.29. Key Developments

16. South America Ventricular Assist Device Market Analysis
16.1. Key Findings
16.2. South America Ventricular Assist Device Market Overview
16.3. South America Ventricular Assist Device Market Value Share Analysis, by Product
16.4. South America Ventricular Assist Device Market Forecast, by Product
16.4.1. Left Ventricular Assist Device
16.4.2. Right Ventricular Assist Device
16.4.3. Bi-Ventricular Assist Device
16.5. South America Ventricular Assist Device Market Value Share Analysis, by Flow
16.6. South America Ventricular Assist Device Market Forecast, by Flow
16.6.1. Pulsatile Flow
16.6.2. Continuous Flow
16.7. South America Ventricular Assist Device Market Value Share Analysis, by Application
16.8. South America Ventricular Assist Device Market Forecast, by Application
16.8.1. Bridge to Transplant
16.8.2. Destination Therapy
16.8.3. Bridge-to-recovery Therapy
16.8.4. Bridge-to-candidacy Therapy
16.8.5. Others
16.9. South America Ventricular Assist Device Market Value Share Analysis, by Design
16.10. South America Ventricular Assist Device Market Forecast, by Design
16.10.1. Transcutaneous Ventricular Assist Devices
16.10.2. Implantable Ventricular Assist Devices
16.11. South America Ventricular Assist Device Market Value Share Analysis, by Country
16.12. South America Ventricular Assist Device Market Forecast, by Country
16.12.1. Brazil
16.12.2. Mexico
16.12.3. Rest of South America
16.13. South America Ventricular Assist Device Market Analysis, by Country
16.14. Brazil Ventricular Assist Device Market Forecast, by Product
16.14.1. Left Ventricular Assist Device
16.14.2. Right Ventricular Assist Device
16.14.3. Bi-Ventricular Assist Device
16.15. Brazil Ventricular Assist Device Market Forecast, by Flow
16.15.1. Pulsatile Flow
16.15.2. Continuous Flow
16.16. Brazil Ventricular Assist Device Market Forecast, by Application
16.16.1. Bridge to Transplant
16.16.2. Destination Therapy
16.16.3. Bridge-to-recovery Therapy
16.16.4. Bridge-to-candidacy Therapy
16.16.5. Others
16.17. Brazil Ventricular Assist Device Market Forecast, by Design
16.17.1. Transcutaneous Ventricular Assist Devices
16.17.2. Implantable Ventricular Assist Devices
16.18. Mexico Ventricular Assist Device Market Forecast, by Product
16.18.1. Left Ventricular Assist Device
16.18.2. Right Ventricular Assist Device
16.18.3. Bi-Ventricular Assist Device
16.19. Mexico Ventricular Assist Device Market Forecast, by Flow
16.19.1. Pulsatile Flow
16.19.2. Continuous Flow
16.20. Mexico Ventricular Assist Device Market Forecast, by Application
16.20.1. Bridge to Transplant
16.20.2. Destination Therapy
16.20.3. Bridge-to-recovery Therapy
16.20.4. Bridge-to-candidacy Therapy
16.20.5. Others
16.21. Mexico Ventricular Assist Device Market Forecast, by Design
16.21.1. Transcutaneous Ventricular Assist Devices
16.21.2. Implantable Ventricular Assist Devices
16.22. Rest of South America Ventricular Assist Device Market Forecast, by Product
16.22.1. Left Ventricular Assist Device
16.22.2. Right Ventricular Assist Device
16.22.3. Bi-Ventricular Assist Device
16.23. Rest of South America Ventricular Assist Device Market Forecast, by Flow
16.23.1. Pulsatile Flow
16.23.2. Continuous Flow
16.24. Rest of South America Ventricular Assist Device Market Forecast, by Application
16.24.1. Bridge to Transplant
16.24.2. Destination Therapy
16.24.3. Bridge-to-recovery Therapy
16.24.4. Bridge-to-candidacy Therapy
16.24.5. Others
16.25. Rest of South America Ventricular Assist Device Market Forecast, by Design
16.25.1. Transcutaneous Ventricular Assist Devices
16.25.2. Implantable Ventricular Assist Devices
16.26. South America Ventricular Assist Device Market Attractiveness Analysis
16.26.1. By Product
16.26.2. By Flow
16.26.3. By Application
16.26.4. By Design
16.27. PEST Analysis
16.28. Key Trends
16.29. Key Developments

17. Company Profiles
17.1. Market Share Analysis, by Company
17.2. Competition Matrix
17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
17.2.2. New Product Launches and Product Enhancements
17.2.3. Market Consolidation
17.2.3.1. M&A by Regions, Investment and Applications
17.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
17.3. Company Profiles: Key Players
17.3.1. CardiacAssist, Inc.
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. Business Strategy
17.3.1.5. Recent Developments
17.3.1.6. Manufacturing Footprint
17.3.1.7. Berlin Heart GmbH
17.3.1.8. Jarvik Heart, Inc.
17.3.1.9. ABIOMED, Inc.
17.3.1.10. Medtronic plc.
17.3.1.11. Abbott Laboratories
17.3.1.12. ReliantHeart Inc.
17.3.1.13. Teleflex Incorporated
17.3.1.14. Carmat SA
17.3.1.15. Sun Medical Technology Research Corp.
17.3.1.16. Bivacor
17.3.1.17. Calon Cardio-Technology Ltd.
17.3.1.18. LivaNova PLC
17.3.1.19. Terumo Medical Corporation.
17.3.1.20. Evaheart Medical USA, Inc.
17.3.1.21. Fresenius Medical Care AG & Co. KGaA
17.3.1.22. Maquet GmbH
17.3.1.23. HeartWare International, Inc.

18. Primary Key Insights
  • INQUIRE BEFORE BUYING